Agenus Inc (AGEN) stock
AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.21−0.08 (-1.27%)
Close on Nov 17, 2026Market cap $279.58MP/E –Yield –
Agenus revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Agenus's revenue for the twelve months ending Jun 30, 2026 was $132.69M, up 30.5% year over year. For fiscal 2025 it was $114.20M, up 10.4% from the year before. Over ten years it grew 16.5% a year on average. The highest annual figure on record is $295.67M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.20M | +10.4% |
| FY2024 | Dec 31, 2024 | $103.46M | -33.8% |
| FY2023 | Dec 31, 2023 | $156.31M | +59.5% |
| FY2022 | Dec 31, 2022 | $98.02M | -66.8% |
| FY2021 | Dec 31, 2021 | $295.67M | +235.3% |
| FY2020 | Dec 31, 2020 | $88.17M | -41.2% |
| FY2019 | Dec 31, 2019 | $150.05M | +307.9% |
| FY2018 | Dec 31, 2018 | $36.78M | -14.2% |
| FY2017 | Dec 31, 2017 | $42.88M | +89.9% |
| FY2016 | Dec 31, 2016 | $22.57M | -9.0% |
| FY2015 | Dec 31, 2015 | $24.82M | +255.7% |
| FY2014 | Dec 31, 2014 | $6.98M | +129.1% |
| FY2013 | Dec 31, 2013 | $3.05M | -80.9% |
| FY2012 | Dec 31, 2012 | $15.96M | +479.2% |
| FY2011 | Dec 31, 2011 | $2.76M | -18.0% |
| FY2010 | Dec 31, 2010 | $3.36M | +0.8% |
| FY2009 | Dec 31, 2009 | $3.33M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $34.52M | +34.4% |
| Q1 FY2026 | Mar 31, 2026 | $33.74M | +40.2% |
| Q4 FY2025 | Dec 31, 2025 | $34.20M | +27.5% |
| Q3 FY2025 | Sep 30, 2025 | $30.24M | +20.4% |
| Q2 FY2025 | Jun 30, 2025 | $25.69M | +9.3% |
| Q1 FY2025 | Mar 31, 2025 | $24.07M | -14.1% |
| Q4 FY2024 | Dec 31, 2024 | $26.84M | -68.0% |
| Q3 FY2024 | Sep 30, 2024 | $25.11M | +3.3% |
| Q2 FY2024 | Jun 30, 2024 | $23.51M | -7.1% |
| Q1 FY2024 | Mar 31, 2024 | $28.01M | +22.3% |
| Q4 FY2023 | Dec 31, 2023 | $83.80M | +195.2% |
| Q3 FY2023 | Sep 30, 2023 | $24.31M | +6.8% |
| Q2 FY2023 | Jun 30, 2023 | $25.30M | +20.9% |
| Q1 FY2023 | Mar 31, 2023 | $22.90M | -11.7% |
| Q4 FY2022 | Dec 31, 2022 | $28.39M | +40.1% |
| Q3 FY2022 | Sep 30, 2022 | $22.77M | -91.0% |
| Q2 FY2022 | Jun 30, 2022 | $20.93M | +95.0% |
| Q1 FY2022 | Mar 31, 2022 | $25.94M | +121.4% |
| Q4 FY2021 | Dec 31, 2021 | $20.26M | -35.2% |
| Q3 FY2021 | Sep 30, 2021 | $252.95M | +1605.5% |
| Q2 FY2021 | Jun 30, 2021 | $10.73M | -60.2% |
| Q1 FY2021 | Mar 31, 2021 | $11.72M | -22.5% |
| Q4 FY2020 | Dec 31, 2020 | $31.27M | -9.4% |
| Q3 FY2020 | Sep 30, 2020 | $14.83M | -25.6% |
| Q2 FY2020 | Jun 30, 2020 | $26.95M | +71.5% |
| Q1 FY2020 | Mar 31, 2020 | $15.13M | -81.1% |
| Q4 FY2019 | Dec 31, 2019 | $34.50M | +434.8% |
| Q3 FY2019 | Sep 30, 2019 | $19.94M | +55.8% |
| Q2 FY2019 | Jun 30, 2019 | $15.72M | -1.1% |
| Q1 FY2019 | Mar 31, 2019 | $79.89M | +4783.3% |
| Q4 FY2018 | Dec 31, 2018 | $6.45M | -22.8% |
| Q3 FY2018 | Sep 30, 2018 | $12.80M | +281.1% |
| Q2 FY2018 | Jun 30, 2018 | $15.90M | +277.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.64M | -93.9% |
| Q4 FY2017 | Dec 31, 2017 | $8.35M | +49.8% |
| Q3 FY2017 | Sep 30, 2017 | $3.36M | -24.4% |
| Q2 FY2017 | Jun 30, 2017 | $4.21M | – |
| Q1 FY2017 | Mar 31, 2017 | $26.96M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.58M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.45M | – |
See a number that looks wrong?